[1]
“Pharmacotherapy Considerations in CKD Patients With COVID-19, A Narrative Review”, IJKD, vol. 14, no. 4, pp. 247–255, Jul. 2020, Accessed: May 16, 2024. [Online]. Available: https://www.ijkd.org/index.php/ijkd/article/view/5600